Gemcitabine Hydrochloride for Injection Clinical Trials
12 recruitingDrug
Phase 39Phase 23Phase 11
Showing 1–12 of 12 trials
Recruiting
Phase 3
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
Recurrent Cervical CancerMetastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.398 enrolled1 locationNCT07418749
Recruiting
Phase 2
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd140 enrolled6 locationsNCT07111546
Recruiting
Phase 3
Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer
Pancreatic Cancer Metastatic
Shanghai Yizhong Pharmaceutical Co., Ltd.416 enrolled2 locationsNCT06752811
Recruiting
Phase 2
Cosiporfin Sodium for Injection Photodynamic Therapy
Biliary Tract Cancers (BTC)
Shanghai Guangsheng Biopharmaceutical Co., Ltd30 enrolled1 locationNCT07398339
Recruiting
Phase 3
A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)
Advanced Biliary Tract Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.604 enrolled1 locationNCT07229625
Recruiting
Phase 1Phase 2
A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors
Solid Tumor
Shanghai Hengrui Pharmaceutical Co., Ltd.100 enrolled1 locationNCT07229586
Recruiting
Phase 3
A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.280 enrolled2 locationsNCT06929624
Recruiting
Phase 3
A Phase III Study of SHR-A2102 Versus Investigator-selected Therapy in Advanced Urothelial Carcinoma
Advanced Urothelial Carcinoma
Shanghai Hengrui Pharmaceutical Co., Ltd.402 enrolled1 locationNCT06738251
Recruiting
Phase 3
A Study of SHR-A1811 in Subjects With Ovarian Cancer
Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd.300 enrolled2 locationsNCT06828354
Recruiting
Phase 3
Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
BeBetter Med Inc416 enrolled1 locationNCT06792253
Recruiting
Phase 3
Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer
Metastatic Breast Cancer (MBC)
Shanghai Yizhong Pharmaceutical Co., Ltd.168 enrolled3 locationsNCT06143553
Recruiting
Phase 3
A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer
Advanced or Metastatic Urothelium Cancer
Shanghai Miracogen Inc.290 enrolled1 locationNCT05754853